Investigations
Centro Hospitalar de Leiria, EPE
Automated case report generated from contract-level risk evidence.
Executive Highlights
3 companies receive 17.6% of total spend
14,147 of 18,836 contracts (75.1%) have active risk signals
Supplier concentration is low (HHI 0.0286)
728 individuals (aggregate count) linked to 98 winner companies
60 individuals are linked to multiple winner companies
Person-company link evidence is available for 98 of 930 winner companies (10.5%); 832 have no link data
Award timing distribution is within expected bounds: 30.9% in Mar/Jun/Sep/Dec; 7% in December
Key Metrics
Flagged Rate
flagged_contracts / total_contracts = 14,147 / 18,836 = 75.1%
HHI Concentration
HHI = Σ s_i² = 0.0286
Interpretation: low supplier concentration
Thresholds: low < 0.15; medium 0.15-0.25; high > 0.25
| Company | Awarded value | Share |
|---|---|---|
| JANSSEN - CILAG FARMACÊUTICA LDA | €1,387,505,100 | 6.7% |
| NOVARTIS FARMA - PRODUTOS FARMACÊUTICOS S.A. | €1,230,279,091 | 5.9% |
| LABORATÓRIOS PFIZER LDA | €1,044,515,760 | 5% |
Network Cluster Map
Main cluster focused on this entity with person-company links.
Whole Procurement Map
Global contract links across public bodies and companies
Public mode hides individual nodes and shows only connected-individual totals.
Loading network…
No connections found for the current filters.
Navigate: drag to pan, use mouse wheel to zoom, and reset view when needed.
Legend
Public body
Company
Top 30 High-Risk Contracts
Highest combined risk score, with indicator evidence.
| Contract | Date | Value | Risk | Evidence |
|---|---|---|---|---|
|
J0/1854/2024 Construção de paredes entre dois prédios contíguos
10772319
|
2024-05-14 | €4,755 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=4899
A2 · Late Publication
(40)
publication_date=2024-06-18 | celebration_date=2024-05-14
A5 · Threshold Splitting
(35)
base_price=4755.0 | threshold=5000.0
|
|
Sacos Plástico
2979336
|
2016-11-30 | €67,118 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=43123
A2 · Late Publication
(40)
publication_date=2017-02-03 | celebration_date=2016-11-30
A5 · Threshold Splitting
(35)
base_price=74937.0 | threshold=75000.0
|
|
SACOS PLÁSTICO
2300763
|
2015-12-14 | €67,971 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=43123
A2 · Late Publication
(40)
publication_date=2016-07-21 | celebration_date=2015-12-14
A5 · Threshold Splitting
(35)
base_price=73890.0 | threshold=75000.0
|
|
SACOS PLÁSTICO
2232050
|
2015-12-14 | €73,890 | 125 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=43123
A2 · Late Publication
(40)
publication_date=2016-06-09 | celebration_date=2015-12-14
A5 · Threshold Splitting
(35)
base_price=74075.0 | threshold=75000.0
|
|
P2/3332/2023 MATERIAL PARA TERAPIA PRESSÃO NEGATIVA
10540101
|
2024-01-03 | €1,583,056 | 115 (3) |
A9 · Price Overrun
(55)
base_price=23877.0 | total_effective_price=1583056.0
A2 · Late Publication
(40)
publication_date=2024-02-05 | celebration_date=2024-01-03
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
A2/2091/2025 - CP Diverso Material de Consumo Clinico
11851682
|
2025-10-15 | €1,680 | 110 (4) |
A2 · Late Publication
(40)
publication_date=2025-10-28 | celebration_date=2025-10-15
A5 · Threshold Splitting
(35)
base_price=146317.0 | threshold=150000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
A2/1342/2020 - Material para Eletromedicina
10794846
|
2020-10-07 | €292 | 110 (4) |
A2 · Late Publication
(40)
publication_date=2024-06-28 | celebration_date=2020-10-07
A5 · Threshold Splitting
(35)
base_price=143345.0 | threshold=150000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
Fios de Sutura
9261075
|
2022-04-08 | €1,955 | 110 (4) |
A2 · Late Publication
(40)
publication_date=2022-05-16 | celebration_date=2022-04-08
A5 · Threshold Splitting
(35)
base_price=4999.0 | threshold=5000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
Q1/1753/2019 Medicamentos do Grupo 4: Sangue
6099249
|
2019-11-25 | €2,663 | 110 (4) |
A2 · Late Publication
(40)
publication_date=2019-12-10 | celebration_date=2019-11-25
A5 · Threshold Splitting
(35)
base_price=147256.0 | threshold=150000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
E1/2/2018 - ANTISSÉTICOS, DESINFETANTES E OUTROS
4259314
|
2018-01-04 | €483 | 110 (4) |
A2 · Late Publication
(40)
publication_date=2018-02-16 | celebration_date=2018-01-04
A5 · Threshold Splitting
(35)
base_price=4806.0 | threshold=5000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
Ajuste direto para aquisição de B770 - Bevacizumab [25 mg/ml; 100 mg/ 4 ml; conc p/a sol p/a perfusão; frs] doentes em tratamento e B771- Bevacizumab [25 mg/ml; 400 mg/ 16 ml; conc p/a sol p/a perfusão; frs] doentes em tratamento.
11012049
|
2024-10-22 | €21,766 | 110 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=366
A2 · Late Publication
(40)
publication_date=2024-11-07 | celebration_date=2024-10-22
A6 · Low Competition
(20)
rule=a6_single_bidder | bidder_count=1
|
|
J1/1585/2023 - Microbiologia - Cepheid
10699649
|
2023-06-12 | €71,250 | 100 (3) |
A2 · Late Publication
(40)
publication_date=2024-05-06 | celebration_date=2023-06-12
A5 · Threshold Splitting
(35)
base_price=71250.0 | threshold=75000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
E2/1547/2020 Material para CTO (Worlf Médica)
6515501
|
2020-02-10 | €3,100 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=1431
A2 · Late Publication
(40)
publication_date=2020-04-24 | celebration_date=2020-02-10
A9 · Abnormal Price Reduction
(10)
base_price=14037.0 | total_effective_price=3100.0
|
|
E1/78/2020 - Dieta láctea p/ recém-nascido de baixo peso e Suplemento de leite materno p/ prematuros saquetas 2,2g
6309041
|
2020-01-09 | €256 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=8716
A2 · Late Publication
(40)
publication_date=2020-02-11 | celebration_date=2020-01-09
A9 · Abnormal Price Reduction
(10)
base_price=700.0 | total_effective_price=256.0
|
|
Q1/1753/2019 Medicamentos do Grupo 4: Sangue
6099265
|
2019-11-25 | €107,533 | 100 (3) |
A2 · Late Publication
(40)
publication_date=2019-12-10 | celebration_date=2019-11-25
A5 · Threshold Splitting
(35)
base_price=147256.0 | threshold=150000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
E1/169/2019 Reagentes para imunologia
5771743
|
2019-07-24 | €298 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=5915
A2 · Late Publication
(40)
publication_date=2019-08-12 | celebration_date=2019-07-24
A9 · Abnormal Price Reduction
(10)
base_price=7919.0 | total_effective_price=298.0
|
|
E1/430/2019 Antisseticos, Desinfectantes e Outros
5597763
|
2019-02-14 | €3,172 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=109
A2 · Late Publication
(40)
publication_date=2019-05-29 | celebration_date=2019-02-14
A9 · Abnormal Price Reduction
(10)
base_price=15020.0 | total_effective_price=3172.0
|
|
E1/430/2019 Antisseticos, Desinfectantes e Outros
5597738
|
2019-02-14 | €1,202 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=409
A2 · Late Publication
(40)
publication_date=2019-05-29 | celebration_date=2019-02-14
A9 · Abnormal Price Reduction
(10)
base_price=15020.0 | total_effective_price=1202.0
|
|
E1/639/2019 Material de Penso Terapeutico
5594875
|
2019-03-29 | €3,478 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=5278
A2 · Late Publication
(40)
publication_date=2019-05-29 | celebration_date=2019-03-29
A9 · Abnormal Price Reduction
(10)
base_price=21609.0 | total_effective_price=3478.0
|
|
E1/395/2019 Nutrição Entérica II
5577411
|
2019-02-05 | €315 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=325
A2 · Late Publication
(40)
publication_date=2019-05-23 | celebration_date=2019-02-05
A9 · Abnormal Price Reduction
(10)
base_price=9212.0 | total_effective_price=315.0
|
|
E1/395/2019 Nutrição Entérica II
5577425
|
2019-02-05 | €1,687 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=225
A2 · Late Publication
(40)
publication_date=2019-05-23 | celebration_date=2019-02-05
A9 · Abnormal Price Reduction
(10)
base_price=9212.0 | total_effective_price=1687.0
|
|
E1/395/2019 Nutrição Entérica II
5577413
|
2019-04-09 | €2,527 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=225
A2 · Late Publication
(40)
publication_date=2019-05-23 | celebration_date=2019-04-09
A9 · Abnormal Price Reduction
(10)
base_price=9212.0 | total_effective_price=2527.0
|
|
E7/541/2018 Contrato Auditoria de Reacreditação - JCI
5551616
|
2018-08-07 | €74,382 | 100 (3) |
A2 · Late Publication
(40)
publication_date=2019-05-15 | celebration_date=2018-08-07
A5 · Threshold Splitting
(35)
base_price=74382.0 | threshold=75000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
MEIA COTO EM ALGODÃO
5526052
|
2019-01-23 | €36 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=415
A2 · Late Publication
(40)
publication_date=2019-05-06 | celebration_date=2019-01-23
A9 · Abnormal Price Reduction
(10)
base_price=120.0 | total_effective_price=36.0
|
|
E1/00000060/2019 - Medicamentos Exclusivos Orphan Europe
5427630
|
2019-01-16 | €4,953 | 100 (3) |
A2 · Late Publication
(40)
publication_date=2019-03-29 | celebration_date=2019-01-16
A5 · Threshold Splitting
(35)
base_price=4953.0 | threshold=5000.0
C1 · Missing Supplier NIF
(25)
rule=C1 no winner recorded: awarded contract (effective price > 0) has no supplier identified
|
|
E1/00001362/2018 - Reagentes para Imunologia
5296221
|
2018-11-30 | €1,000 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=5915
A2 · Late Publication
(40)
publication_date=2019-02-27 | celebration_date=2018-11-30
A9 · Abnormal Price Reduction
(10)
base_price=2129.0 | total_effective_price=1000.0
|
|
Produtos de Limpeza
4877578
|
2018-02-05 | €714 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=14489
A2 · Late Publication
(40)
publication_date=2018-10-16 | celebration_date=2018-02-05
A9 · Abnormal Price Reduction
(10)
base_price=30265.0 | total_effective_price=714.0
|
|
Produtos Limpeza
4878009
|
2018-02-05 | €12,376 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=14489
A2 · Late Publication
(40)
publication_date=2018-10-16 | celebration_date=2018-02-05
A9 · Abnormal Price Reduction
(10)
base_price=30265.0 | total_effective_price=12376.0
|
|
Consumíveis de Impressão Compatíveis
4566711
|
2017-07-03 | €1,391 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=17994
A2 · Late Publication
(40)
publication_date=2018-06-21 | celebration_date=2017-07-03
A9 · Abnormal Price Reduction
(10)
base_price=5029.0 | total_effective_price=1391.0
|
|
Material de penso
4513545
|
2018-01-05 | €484 | 100 (3) |
A1 · Repeat Direct Award
(50)
authority_id=55 | supplier_id=792
A2 · Late Publication
(40)
publication_date=2018-05-29 | celebration_date=2018-01-05
A9 · Abnormal Price Reduction
(10)
base_price=31776.0 | total_effective_price=484.0
|
Award Timeline
Monthly award volume and amendment risk signals.
| Period | Awards | Awarded value | Amendment signals |
|---|---|---|---|
| 2013-12 | 1 | €5,690 | 0 |
| 2014-04 | 2 | €488,134 | 0 |
| 2014-07 | 2 | €142,304 | 0 |
| 2014-08 | 1 | €144,000 | 0 |
| 2014-09 | 2 | €11,803 | 0 |
| 2014-10 | 2 | €51,515 | 0 |
| 2014-12 | 7 | €65,616 | 0 |
| 2015-01 | 173 | €2,820,360 | 0 |
| 2015-02 | 20 | €263,055 | 0 |
| 2015-03 | 29 | €536,236 | 0 |
| 2015-04 | 38 | €470,312 | 0 |
| 2015-05 | 19 | €351,910 | 0 |
| 2015-06 | 49 | €800,797 | 0 |
| 2015-07 | 29 | €372,764 | 0 |
| 2015-08 | 12 | €135,695 | 0 |
| 2015-09 | 19 | €285,971 | 0 |
| 2015-10 | 32 | €365,147 | 0 |
| 2015-11 | 14 | €167,807 | 0 |
| 2015-12 | 46 | €1,736,692 | 0 |
| 2016-01 | 213 | €3,520,628 | 0 |
| 2016-02 | 44 | €1,721,647 | 0 |
| 2016-03 | 72 | €3,116,919 | 0 |
| 2016-04 | 107 | €2,593,616 | 0 |
| 2016-05 | 108 | €3,113,944 | 0 |
| 2016-06 | 70 | €4,479,437 | 0 |
| 2016-07 | 56 | €2,242,165 | 0 |
| 2016-08 | 101 | €1,135,073 | 0 |
| 2016-09 | 51 | €3,203,381 | 0 |
| 2016-10 | 77 | €1,299,566 | 0 |
| 2016-11 | 61 | €1,328,384 | 0 |
| 2016-12 | 79 | €1,531,086 | 0 |
| 2017-01 | 242 | €3,359,868 | 0 |
| 2017-02 | 122 | €3,130,763 | 0 |
| 2017-03 | 183 | €3,775,902 | 0 |
| 2017-04 | 165 | €3,939,635 | 0 |
| 2017-05 | 125 | €2,480,964 | 0 |
| 2017-06 | 133 | €4,235,464 | 0 |
| 2017-07 | 120 | €1,341,287 | 0 |
| 2017-08 | 203 | €1,828,234 | 0 |
| 2017-09 | 87 | €628,925 | 0 |
| 2017-10 | 58 | €1,273,527 | 0 |
| 2017-11 | 86 | €902,784 | 0 |
| 2017-12 | 139 | €4,737,402 | 0 |
| 2018-01 | 362 | €3,483,450 | 0 |
| 2018-02 | 196 | €1,982,883 | 0 |
| 2018-03 | 211 | €1,565,126 | 0 |
| 2018-04 | 249 | €2,184,484 | 0 |
| 2018-05 | 127 | €731,990 | 0 |
| 2018-06 | 115 | €785,813 | 0 |
| 2018-07 | 105 | €1,519,354 | 0 |
| 2018-08 | 84 | €723,316 | 0 |
| 2018-09 | 96 | €1,681,790 | 0 |
| 2018-10 | 80 | €336,468 | 0 |
| 2018-11 | 68 | €527,424 | 0 |
| 2018-12 | 134 | €3,039,626 | 0 |
| 2019-01 | 197 | €5,081,696 | 0 |
| 2019-02 | 121 | €1,937,995 | 0 |
| 2019-03 | 115 | €2,459,411 | 0 |
| 2019-04 | 125 | €1,307,612 | 0 |
| 2019-05 | 121 | €2,607,408 | 0 |
| 2019-06 | 128 | €1,869,753 | 0 |
| 2019-07 | 109 | €2,077,042 | 0 |
| 2019-08 | 131 | €1,927,712 | 0 |
| 2019-09 | 108 | €1,126,670 | 0 |
| 2019-10 | 95 | €1,310,719 | 0 |
| 2019-11 | 117 | €1,291,814 | 0 |
| 2019-12 | 166 | €6,117,766 | 0 |
| 2020-01 | 169 | €7,417,994 | 0 |
| 2020-02 | 154 | €3,737,250 | 0 |
| 2020-03 | 239 | €2,945,806 | 0 |
| 2020-04 | 229 | €2,538,680 | 0 |
| 2020-05 | 250 | €1,912,668 | 0 |
| 2020-06 | 153 | €2,575,680 | 0 |
| 2020-07 | 147 | €3,744,287 | 0 |
| 2020-08 | 101 | €4,498,632 | 0 |
| 2020-09 | 120 | €1,854,779 | 0 |
| 2020-10 | 183 | €2,458,355 | 0 |
| 2020-11 | 198 | €3,334,605 | 0 |
| 2020-12 | 114 | €1,291,860 | 0 |
| 2021-01 | 296 | €6,005,179 | 0 |
| 2021-02 | 202 | €4,536,411 | 0 |
| 2021-03 | 229 | €5,847,942 | 0 |
| 2021-04 | 178 | €2,689,601 | 0 |
| 2021-05 | 211 | €2,603,991 | 0 |
| 2021-06 | 139 | €3,434,704 | 0 |
| 2021-07 | 147 | €2,667,614 | 0 |
| 2021-08 | 154 | €3,396,542 | 0 |
| 2021-09 | 95 | €2,059,710 | 0 |
| 2021-10 | 106 | €1,884,278 | 0 |
| 2021-11 | 98 | €1,205,096 | 0 |
| 2021-12 | 96 | €3,757,708 | 0 |
| 2022-01 | 142 | €4,802,811 | 0 |
| 2022-02 | 118 | €6,674,076 | 0 |
| 2022-03 | 182 | €6,687,487 | 0 |
| 2022-04 | 136 | €2,546,933 | 0 |
| 2022-05 | 178 | €518,300,275 | 0 |
| 2022-06 | 141 | €3,416,981 | 0 |
| 2022-07 | 157 | €5,097,856 | 0 |
| 2022-08 | 143 | €4,745,591 | 0 |
| 2022-09 | 115 | €2,737,262 | 0 |
| 2022-10 | 96 | €2,465,694 | 0 |
| 2022-11 | 96 | €4,251,275 | 0 |
| 2022-12 | 99 | €2,701,814 | 0 |
| 2023-01 | 149 | €3,123,667 | 0 |
| 2023-02 | 139 | €10,394,742 | 0 |
| 2023-03 | 177 | €8,890,158 | 0 |
| 2023-04 | 169 | €3,024,765 | 0 |
| 2023-05 | 184 | €2,117,056 | 0 |
| 2023-06 | 167 | €3,855,205 | 0 |
| 2023-07 | 211 | €6,838,543 | 0 |
| 2023-08 | 191 | €9,571,993 | 0 |
| 2023-09 | 231 | €3,483,077 | 0 |
| 2023-10 | 189 | €5,605,338 | 0 |
| 2023-11 | 176 | €4,250,113 | 0 |
| 2023-12 | 171 | €4,437,886 | 0 |
| 2024-01 | 143 | €4,294,527 | 0 |
| 2024-02 | 280 | €10,456,868 | 0 |
| 2024-03 | 221 | €6,042,791 | 0 |
| 2024-04 | 216 | €5,217,655 | 0 |
| 2024-05 | 210 | €7,847,454 | 0 |
| 2024-06 | 142 | €2,396,477 | 0 |
| 2024-07 | 226 | €20,320,727 | 0 |
| 2024-08 | 158 | €4,936,170 | 0 |
| 2024-09 | 176 | €5,725,338 | 0 |
| 2024-10 | 192 | €5,186,050 | 0 |
| 2024-11 | 148 | €5,822,221 | 0 |
| 2024-12 | 181 | €4,280,186 | 0 |
| 2025-01 | 163 | €3,294,704 | 0 |
| 2025-02 | 206 | €10,105,699 | 0 |
| 2025-03 | 188 | €12,188,681 | 0 |
| 2025-04 | 268 | €8,360,299 | 0 |
| 2025-05 | 126 | €5,519,709 | 0 |
| 2025-06 | 173 | €4,928,915 | 0 |
| 2025-07 | 229 | €15,904,142 | 0 |
| 2025-08 | 132 | €6,174,664 | 0 |
| 2025-09 | 143 | €13,854,845 | 0 |
| 2025-10 | 205 | €10,226,723 | 0 |
| 2025-11 | 128 | €8,067,592 | 0 |
| 2025-12 | 94 | €2,692,103 | 0 |
| 2026-01 | 110 | €9,188,263 | 0 |
| 2026-02 | 54 | €3,093,127 | 0 |
Risk scoring combines rule-based indicators with data quality flags. Values and confidence degrade when critical fields are missing.